CDKN2A and neoplasm: There was no significant association of L1 seropositivity (p = 0.186), a negative p16 expression (p = 0.360), tumor recurrence (p = 0.586), differentiation grad (p = 0.157), or lymph node metastasis (p = 0.119) on overall survival.